A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder

A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder

Objective: Selective serotonin reuptake inhibitors like sertraline have been shown in observational studies and anecdotal reports to improve language development in young children with fragile X syndrome (FXS). A previous controlled trial of sertraline in young children with FXS found significant im...

Full description

Bibliographic Details
Main Authors: Laura A. Potter, Danielle A. Scholze, Hazel Maridith B. Biag, Andrea Schneider, Yanjun Chen, Danh V. Nguyen, Akash Rajaratnam, Susan M. Rivera, Patrick S. Dwyer, Flora Tassone, Reem R. Al Olaby, Nimrah S. Choudhary, Maria J. Salcedo-Arellano, Randi J. Hagerman
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Psychiatry
Subjects:
sertraline
autism spectrum disorder
controlled trial
targeted treatment
nonsyndromic autism spectrum disorder
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2019.00810/full

Similar Items

Similar Items